Sumitomo Mitsui Trust Holdings, Inc. Beam Therapeutics Inc. Transaction History

Sumitomo Mitsui Trust Holdings, Inc.

  • $156 Billion
  • Q2 2025

A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 4,729,444 shares of BEAM stock, worth $101 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
4,729,444
Previous 4,266,871 10.84%
Holding current value
$101 Million
Previous $83.3 Million 3.46%
% of portfolio
0.05%
Previous 0.06%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 31, 2025
BUY
$14.54 - $20.24 $6.73 Million - $9.36 Million
462,573 Added 10.84%
4,729,444 $80.4 Million
Q1 2025

Apr 25, 2025
BUY
$19.53 - $34.09 $6.04 Million - $10.5 Million
309,260 Added 7.81%
4,266,871 $83.3 Million
Q4 2024

Jan 28, 2025
BUY
$21.55 - $30.35 $8.72 Million - $12.3 Million
404,782 Added 11.39%
3,957,611 $98.1 Million
Q3 2024

Nov 05, 2024
BUY
$22.57 - $33.14 $30 Million - $44 Million
1,328,414 Added 59.72%
3,552,829 $87 Million
Q2 2024

Jul 19, 2024
SELL
$21.22 - $32.66 $2.92 Million - $4.49 Million
-137,402 Reduced 5.82%
2,224,415 $52.1 Million
Q1 2024

Apr 19, 2024
BUY
$23.46 - $45.07 $87,411 - $167,930
3,726 Added 0.16%
2,361,817 $78 Million
Q4 2023

Jan 30, 2024
BUY
$17.69 - $30.76 $12.7 Million - $22 Million
715,911 Added 43.6%
2,358,091 $64.2 Million
Q3 2023

Oct 30, 2023
BUY
$23.01 - $32.46 $9.83 Million - $13.9 Million
427,100 Added 35.15%
1,642,180 $39.5 Million
Q2 2023

Jul 31, 2023
BUY
$29.32 - $35.99 $16.3 Million - $20 Million
556,514 Added 84.5%
1,215,080 $38.8 Million
Q1 2023

Apr 27, 2023
SELL
$30.15 - $48.79 $455,988 - $737,899
-15,124 Reduced 2.24%
658,566 $20.2 Million
Q4 2022

Jan 30, 2023
BUY
$36.73 - $51.6 $5.98 Million - $8.4 Million
162,759 Added 31.86%
673,690 $26.3 Million
Q3 2022

Oct 21, 2022
BUY
$39.79 - $70.31 $8.71 Million - $15.4 Million
218,969 Added 75.0%
510,931 $24.3 Million
Q2 2022

Jul 26, 2022
BUY
$29.86 - $62.36 $252,406 - $527,129
8,453 Added 2.98%
291,962 $11.3 Million
Q1 2022

Apr 27, 2022
BUY
$53.73 - $82.16 $3.13 Million - $4.79 Million
58,286 Added 25.88%
283,509 $16.2 Million
Q4 2021

Feb 02, 2022
SELL
$68.02 - $99.06 $1.98 Million - $2.89 Million
-29,132 Reduced 11.45%
225,223 $17.9 Million
Q3 2021

Oct 25, 2021
SELL
$84.37 - $133.6 $186,457 - $295,256
-2,210 Reduced 0.86%
254,355 $22.1 Million
Q2 2021

Aug 02, 2021
BUY
$64.12 - $128.71 $1.74 Million - $3.5 Million
27,164 Added 11.84%
256,565 $33 Million
Q1 2021

Apr 30, 2021
BUY
$71.28 - $120.75 $1.79 Million - $3.04 Million
25,159 Added 12.32%
229,401 $18.4 Million
Q4 2020

Feb 05, 2021
BUY
$22.24 - $95.63 $4.54 Million - $19.5 Million
204,242 New
204,242 $16.7 Million

Others Institutions Holding BEAM

# of Institutions
247
Shares Held
95.7M
Call Options Held
666K
Put Options Held
1.99M
View Full List

About Beam Therapeutics Inc.

BEAM Quotes by TradingView
  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.5B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Sumitomo Mitsui Trust Holdings, Inc. Portfolio

Follow Sumitomo Mitsui Trust Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Trust Holdings, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email